The page lists 32 projects related to the topic "immunosuppression".
| # | |||
|---|---|---|---|
| 1 | Rethyming | Rebuilding the human thymus to create a tolerising system for allogeneic tissue and organ transplantation | 2015 |
| 2 | SEPCELL | Title of Proposal: Restoring the immune system homeostasis and organ function in severe community acquired pneumonia- induced sepsis through adipose derived allogeneic stem cells (SEPCELL Proje | 2015 |
| 3 | MEDIuM | Mobile wireless Device microcantilever-based biosensor to identify and measure the aflatoxin B1 in animal food and M1 in the milk-chain | 2015 |
| 4 | RELENT | RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities | 2015 |
| 5 | INTENS | INtestinal Tissue ENgineering Solution | 2016 |
| 6 | TARG-SUP | Targeting TGF-β activation, likely the core mechanism of immunosuppression by human regulatory T cells. | 2016 |
| 7 | PRECIOUS | Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy | 2016 |
| 8 | DISTRICT | DECIPHERING THE ROLE OF TRIB1 IN REGULATORY T CELLS | 2017 |
| 9 | ToxoPersist | Molecular Basis of Toxoplasma gondii Encystation and Persistence | 2016 |
| 10 | uPROPHET | uPROPHET: Urinary PROteomics in Predicting HEart Transplantation outcomes | 2016 |
| 11 | MaRiA | Microbiota and Resolvins in Arthritis | 2017 |
| 12 | CriTiClean | Supercritical carbon dioxide for delipidation of soft tissue - Suppressing transplant rejection. | 2017 |
| 13 | P-TEV | Personalized Tissue-Engineered Veins as the first Cure for Patients with Chronic Venous Insufficiency | 2017 |
| 14 | New Chol | Development of New therapies against cholangiopathies. | 2017 |
| 15 | Io-EMP | Tissue-derived acellular micro-scaffold technology reducing or eliminating diabetics’ dependence oninsulin therapy | 2017 |
| 16 | ImmunoFit | Harnessing tumor metabolism to overcome immunosupression | 2018 |
| 17 | SKin SCiENCE | Skin Keratinocyte Stem CEll proliferatioN in field CancErisation | 2018 |
| 18 | FUCTURE | Fucosylated Clusterin: a novel mechanism of tumor escape from immune response | 2018 |
| 19 | SUMMIT | Stepping Up mRNA Mutanome Immunotherapy | 2018 |
| 20 | StopAutoimmunity | Recurrent disease in the liver transplant: window to identify and stop gut signals driving autoimmunity | 2019 |
| 21 | 3DBIOLUNG | Bioengineering lung tissue using extracellular matrix based 3D bioprinting | 2019 |
| 22 | ViroPedTher | Oncolytic viruses for the treatment of pediatric brain tumors: An integrated clinical and lab approach | 2019 |
| 23 | StopIG | Translating fundamental insights in podocyte metabolism and cell cycle regulation: development of a new treatment for Stopping crescentic Immune Glomerulonephritis | 2019 |
| 24 | MGLycan | Targeting hMGL-GalNAc interactions to reverse immune suppression in cancer | 2019 |
| 25 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
| 26 | UNPACK PD-L1 | Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells | 2020 |
| 27 | ARTimmune | Programmable ARTificial immune systems to fight cancer | 2019 |
| 28 | GLYCOSWITCH | Probing the mysteries of sweet “on-off” switches of the human immune system: toward the development of novel glycomimetics against bacterial infections | 2020 |
| 29 | HAP2 | Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia | 2020 |
| 30 | MelImmuneOrg | Deciphering the tumor-immune-microenvironment profile and organization within the tumors of melanoma patients undergoing immunotherapy | 2020 |
| 31 | TESTIMONY | Tumor Endothelial Cells: Gatekeepers Of Anti-Tumor Immunity | 2020 |
| 32 | Immuno-Predictor | Mechanical Biomarkers for Prediction of Cancer Immunotherapy | 2020 |